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A relatively high affinity/avidity of T cell receptor (TCR) recognition for self-peptide bound 
to major histocompatibility complex II (self-pMHC) ligands is a distinctive feature of CD4 
T regulatory (Treg) cells, including their development in the thymus and maintenance of 
their suppressive functions in the periphery. Despite such high self-reactivity, however, all 
thymic-derived peripheral Treg populations are neither homogenous in their phenotype 
nor uniformly immune-suppressive in their function under steady state condition. We show 
here that based on the previously defined heterogeneity in the phenotype of peripheral 
Treg populations, Ly6C expression on Treg marks a lower degree of activation, prolifera-
tion, and differentiation status as well as functional incompetence. We also demonstrate 
that Ly6C expression on Treg in a steady state is either up- or downregulated depending 
on relative amounts of tonic TCR signals derived from its contacts with self-ligands. 
Interestingly, peripheral appearance and maintenance of these Ly6C-expressing Treg 
cells largely differed in an age-dependent manner, with their proportion being continu-
ously increased from perinatal to young adult period but then being gradually declined 
with age. The reduction of Ly6C+ Treg in the aged mice was not due to their augmented 
cell death but rather resulted from downregulation of Ly6C expression. The Ly6C down-
regulation was accompanied by proliferation of Ly6C+ Treg cells and subsequent change 
into Ly6C− effector Treg with concomitant restoration of immune-suppressive activity. 
Importantly, we found that this phenotypic and functional change of Ly6C+ Treg is largely 
driven by conventional effector T cell population. Collectively, these findings suggest a 
potential cross-talk between peripheral Treg subsets and effector T cells and provides 
better understanding for Treg homeostasis and function on maintaining self-tolerance.
Keywords: ly6c, naive cD4 T  regulatory cells, effector cD4 T  regulatory, conventional effector T cells, T cell 
receptor, self-peptide/major histocompatibility complex ligands
inTrODUcTiOn
CD4 T regulatory (Treg) cells are well defined for their potent immune-suppressive activity and 
establishment of self-tolerance, and are known to develop in the thymus as a result of positive 
selection from their thymic precursor cells (CD4+ CD8+ double-positive thymocytes) by relatively a 
high affinity/avidity of T cell receptor (TCR) interactions with self-peptide-major histocompatibility 
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complex II (self-pMHC) ligands, which is referred to as thymic 
(or natural) Treg (tTreg) and constitutes a major population of 
peripheral Treg pools under steady state (1, 2). Despite such 
well-defined high self-reactivity, however, steady-state mature 
Treg populations in the peripheral lymphoid organs are not uni-
formly homogenous but rather heterogenous in their phenotype 
and function, which differ in the levels of activation-associated 
surface markers, such as CD44 and CD62L, and the degrees of 
immune-suppressive activity, with naive (CD44lo CD62Lhi) and 
effector phenotype (CD44hi CD62Llo) exhibiting the least and 
strongest activity, respectively (3).
Physiological importance of the relatively high self-reactivity 
of tTreg has been demonstrated not only for their thymic deve-
lopment but also for their peripheral survival and function (3). 
It is, therefore, possible that the defined phenotypic and func-
tional heterogeneity within peripheral Treg populations might 
relate to their relative difference in the extent of TCR signaling 
for which they receive from interactions with self-ligands 
under steady state. In this regard, a recent study demonstrated 
that there was indeed a difference in the dependency of TCR 
signaling from self-recognition on the survival between naive 
versus effector Treg populations and that the latter effector cells 
compared to the former readily disappeared in the absence of 
such self-driven tonic TCR signaling (3). Interestingly, this 
study also showed that despite the remaining naive Treg cells 
persisted in the absence of tonic TCR signaling, these cells were 
not functional and thus failed to control conventional T  cell 
activation and proliferation, suggesting an impaired immune-
suppressive capacity of naive Treg cells (3). Although these prior 
observations provide strong evidence for differential depend-
ency of self-reactivity of Treg populations on their peripheral 
homeostasis, however, whether and how these features relate 
to contribute to peripheral Treg pool’s heterogeneity in their 
survival, maintenance, and immune-suppressive function has 
not been fully understood.
With respect to the surface markers allowing for identify-
ing and characterizing Treg phenotypic heterogeneity in an 
unambiguous reliable manner, recent studies have shown that 
steady-state peripheral Treg pools can be subdivided based on 
their surface expression of Ly6C with far clearer distinction 
being made for their relative activation status and functional 
competence compared to the aforementioned combinations of 
CD44 and CD62L expression (4). In a steady-state condition, 
expression of Ly6C on CD4 T cell compartment has been shown 
to occur mainly in naive cells but under inflammatory condi-
tions also found to be induced in effector cells (4–6). Moreover, 
the Ly6C expression on naive CD4 T  cells was shown to be 
influenced by tonic TCR signals derived from self-recognition, 
with surface levels of Ly6C being inversely correlated with rela-
tive avidity of TCR interactions with self-ligands (4). Likewise, 
studies have also shown that Ly6C expression on peripheral Treg 
cell compartment was negatively regulated by such tonic TCR 
signals, low levels of which promote upregulation of Ly6C and 
generate Ly6C+ Treg population under steady state (4). Further 
characterizations with these Ly6C+ Treg cells have demonstrated 
that these cells, unlike their Ly6C− counterparts, display a 
decreased level of Ki-67 expression, a poor immune-suppressive 
activity both in vitro and in vivo, and gradually disappeared with 
age, and thus made a conclusion that the steady-state peripheral 
Ly6C+ Treg cells are non-functional apoptosis-prone popu-
lations (4).
Given their known poor functionality of Ly6C+ Treg cells 
presumably with a minimal contribution to maintaining periph-
eral self-tolerance, it is questionable whether the existence of 
such pro-apoptotic and non-functional Treg subset may have 
any physiological significance. Furthermore, considering the 
nature of Treg of receiving relatively a strong TCR signal from 
self-interactions, it is still unclear how a certain fraction of Treg 
cells would reduce their high intrinsic self-reactivity just below 
a threshold level for responding to self-ligands and become 
quiescent naive Ly6C+ Treg subset. In this report, we show that 
steady-state Treg cells in the periphery compete for their niches 
where they sense and receive a different quantity and quality 
of self-ligands, and that the difference in the response strength 
for self-reactivity contributes to the generation of Ly6C+ Treg 
cells. We also show that the Ly6C+ Treg subset is a unique in 
their ability to downregulate Ly6C expression in a particular 
environment of aging or inflammation, and importantly, this 
change is accompanied by enhanced proliferation and transi-
tion into Ly6C− effector Treg cells via a mechanism involving 
conventional effector T cells. These findings suggest that Ly6C+ 
Treg cells serve as a precursor that can switch into effector Treg 
pools and have a physiological role in balancing self-tolerance 
and immunity.
MaTerials anD MeThODs
Mice
C57BL/6 (B6), Nur77-eGFP (7), Foxp3-eGFP (8), OT-II Rag1−/− 
(9), H2M−/− (10), Rag1−/− (11), IL-2−/− (12), Foxp3-DTR (13), and 
CD11c.DOG Rag1−/− (14) mice were maintained at POSTECH 
Biotech Center (PBC, Korea) under specific pathogen-free 
(SPF) condition. Foxp3-eGFP knock-in mice were a gift from 
Dr. Talal Chatila (University of California at Los Angeles, Los 
Angeles, CA, USA) (8). Thymectomy was performed with 
Foxp3-eGFP mice as previously described (15). Germ-free (GF) 
and antigen-free (AF) mice are maintained at PBC as described 
(16). Unless it is specified, 6–12-week-old mice were used for 
the experiments according to the protocols approved by the 
Animal Experimental and Ethic Committee at the Institute for 
Basic Science (Korea).
Flow cytometry analysis
Cell suspensions were prepared and stained for FACS analysis 
of cell-surface markers using PBS containing 2% FBS and 0.05% 
sodium azide with the following mAbs to (from BD Biosciences, 
Biolegend, and eBioscience): CD3 (145-2C11), CD4 (GK1.5 and 
RM4–5), CD5 (53-7.3), CD8α (53-6.7), CD11b (M1/70), CD11c 
(N418), CD19 (MB19-1), CD24 (M1/69), CD28 (37.51), CD43 
(1B11), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD62L 
(MEL-14), CD69 (H1.2F3), CD90.1 (HIS51 or OX-7), CD25 
(PC61), CD103 (2E7), bromodeoxyuridine (BrdU) (3D4), and 
Ly6C (HK1.4) in a conjugation with FITC, PE, PE-Cy5, PE-Cy7, 
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APC, APC-Cy7, or PB. Propidium iodide (PI) was purchased 
from Sigma Aldrich. To detect dead cell in flow cytometry, PI 
was used at 500  ng/ml of final concentration for staining of 
1–5 × 106 of cells. Flow cytometry samples were run using a LSR 
II or FACSCanto II (BD Biosciences) and analyzed with FlowJo 
software (Tree Star).
BrdU Uptake analysis
Foxp3-eGFP mice were fed with 0.8 mg/ml of BrdU in drinking 
water for 10 days and the BrdU uptake level on Treg subsets were 
analyzed on day 11. BrdU staining was performed according to 
the manufacturer’s protocol (BD biosciences).
Treg subset Purification
Pooled lymph node (LN) cells from the Foxp3-eGFP mice 
were depleted for CD4− cells by series of biotinylated antibody; 
CD8α, CD11b, CD11c, CD24, CD19, B220, and IMag accord-
ing to the manufacturer’s protocol (BD biosciences). Enriched 
cells were stained with PI and fluorochrome-conjugated Abs to 
CD4, Ly6C, CD62L and CD44, and then sorted to obtain CD4+ 
eGFP+ and Ly6C+ CD62Lhi, Ly6C− CD62Lhi, and Ly6C− CD62Llo 
populations. To harvest activated subset of Treg, sorted Treg 
subsets from Thy1.1+ Foxp3-eGFP mice were transferred into 
Foxp3-DTR mice with continuous host Treg depletion by diph-
theria toxin (DT; Sigma Aldrich) treatments. After 2 weeks of 
Treg subset transfer, the transferred Treg cells were reenriched 
from the LN and spleen of the hosts by depleting CD45.2 (104) 
positive cells using magnetic bead. The enriched cells were 
sorted with using a Moflo-XDP (Beckman Coulter). Purity was 
routinely tested after cell sorting and was 95–99%. When Treg 
subsets were transferred into lympho-replete host, the donor 
Treg cells were enriched by biotinylated anti-Thy1.1 (HIS51) 
and magnetic beads. After enrichment of donor cells, Thy1.1 
was stained with fluorochrome-conjugated anti-Thy1.1 (OX7) 
before FACS analysis.
Mixed Bone Marrow (BM) chimera 
generation
Bone marrow cells from CD11c.DOG Rag1−/− were mixed with 
BM cells from wild-type (WT) Rag1−/− mice at the indicated ratio 
and then this mixture of BM cells (50%) were mixed again with 
BM cells from OT-II Thy1.1+ Foxp3-eGFP Rag1−/− mice (50%). 
These BM mixtures (5 × 106) were injected into irradiated Rag1−/− 
hosts (300 cGy). At 8 weeks after BM cell transfer, cells from LN 
and spleen were analyzed by flow cytometry for Ly6C expression 
and CD5.
cell Tracker Violet (cTV) labeling  
and In Vitro Proliferation
FACS-purified subsets of Treg from Foxp3-eGFP mice were 
labeled with CTV (Thermo Fisher Scientific) according to the 
protocol from manufacturer. CTV-labeled Treg cells were cultured 
(5 × 104/well) for 3 days with plate-bound anti-CD3 (5 µg/ml) 
plus indicated cytokines including rmIL-2, rmIL-4, rmIL-9, 
rmIL-21, and TNF-α (all 10 ng/ml). All cytokines were purchased 
from Peprotech.
ly6c Upregulation on recently  
Developed Thymic Treg
To assess Ly6C upregulation by recently developed Treg in 
response to self-antigen competition, thymocytes from 3- to 
4-week-old Foxp3-eGFP mice were enriched for CD8− cells by 
depleting CD8+ cells using magnetic beads. The enriched CD8− 
thymocytes were labeled with CTV and then indicated numbers 
of cells were injected into irradiated B6 hosts (600 cGy).
Tconv cell-Dependent Proliferation  
of Tregnly6c+ Treg
T  regulatory subsets and naive CD4 T  cells were prepared 
as described above. Treg subsets (5 ×  105) were injected into 
Rag1−/− hosts which rose under GF condition. To assess the role 
of conventional T cells (Tconv) on Treg proliferation, 1 × 106 of 
naive CD4 T cells were coinjected where indicated.
adoptive Transfer into Foxp3-DTr  
host with DT Treatment
Wild-type or Foxp3-DTR mice were treated with 1 µg of DT intra-
peritoneally in every other day or every third day as indicated. 
To measure proliferation of donor Treg subsets in Treg-depleted 
host, ~3–5 × 105 of CTV-labeled Treg subsets were injected into 
WT or Foxp3-DTR hosts.
il-2 complex Treatment
1:5 molecular ratios of rmIL-2 and anti-mouse IL-2 (JES6-1) 
(Biolegend) were preincubated (30  min at room temperature). 
The rmIL-2/JES6-1 complex (1/5 μg) was daily injected intra-
peritoneally for on days 0–2. To measure proliferation of donor 
Treg subsets in response to high concentration of IL-2, 5 × 105 of 
CTV-labeled Treg subsets were injected into WT hosts.
statistical analysis
Results represent the mean ± SEM unless indicated otherwise. 
Statistical significance was determined by the unpaired Student’s 
t-test. Statistical analyses were performed using Prism GraphPad 
software v5.0 (*p < 0.05; **p < 0.01; ***p < 0.001).
resUlTs
Phenotypic heterogeneity in Peripheral 
Treg Population
Given the recently defined phenotypic and functional hetero-
geneity of peripheral CD4 Treg populations (4, 17), we sought 
to address whether and how these features relate to their TCR 
reactivity to self-pMHC ligands. We thus first characterized 
phenotypes of peripheral CD4 Treg using Foxp3-GFP reporter 
mice based on the expression of various cell surface markers 
characteristics of naive or activated effector/memory cells.
As shown in Figure 1A, within the peripheral LNs, but not 
thymic, CD4+ Foxp3+ Treg populations, several distinct subsets 
were identifiable mostly based on the expression of CD62L in 
combination with effector-associated markers CD69, CD43, and 
CD103. While subsets expressing low levels of CD62L (CD62Llo) 
FigUre 1 | Phenotypic heterogeneity of peripheral T regulatory (Treg) populations. (a) Lymphocytes from thymus or peripheral lymph nodes (PLN) from  
Foxp3-eGFP mice were analyzed for indicated marker expression. (B) Treg subsets from PLN of Foxp3-eGFP mice were analyzed for CD69, CD103,  
and CD43 expression. The data are representative of three experiments comprising three mice per group. *p < 0.05, **p < 0.01, and ***p < 0.001.
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exhibited more activated phenotypes (higher levels of CD69, 
CD43, and CD103), CD62Lhi subsets appeared to constitute a 
naive pool, although ~15–25% of these CD62Lhi subsets were 
still, albeit lower than those of CD62Llo subsets, able to express 
those activation markers. The clearest phenotypic distinction, 
however, was obtained with the expression of Ly6C, resulting in 
the separation of peripheral Treg cells into largely three distinct 
subpopulations: CD62Llo Ly6C–, CD62Lhi Ly6C–, and CD62Lhi 
Ly6C+ (Figure 1B), subsets of which have also been well char-
acterized by previous studies (18) Consistent with those of prior 
observations, the former subset (CD62Llo Ly6C–) showed an 
activated/effector phenotype with highest levels of CD69, CD43 
and CD103 expression (denoted as TregEff), whereas the latter two 
subsets (CD62Lhi Ly6C− and CD62Lhi Ly6C+) exhibited a naive 
phenotype with either intermediate or lowest amounts of these 
markers (denoted as TregN Ly6C− and TregN Ly6C+, respectively) 
(Figure 1B). These data therefore confirmed the previous notion 
that peripheral Treg cells, large majority of which is thymically 
derived, neuropilin-1-expressing natural Treg (data not shown), 
are heterogenous and largely differ in their cellular activation 
states from one subset to another.
influence of Variable Quantities  
of Tcr self-recognition on ly6c+  
naive Treg generation
The difference in the extent of activation state of peripheral Treg 
pools is intriguing as these cells are known to have a relatively 
strong intrinsic TCR affinity for self-pMHC ligands (2, 17), the 
affinity levels of which is perhaps sufficient to cause a uniform, 
homogenous pattern of effector Treg populations. However, the 
above results showing peripheral existence of a naive state of Treg 
cells raise a possibility that each subset of Treg may differ in their 
relative TCR strength of self-recognition and that the degree of 
such TCR signaling may be quantitatively or qualitatively lower for 
naive subsets, particularly TregN Ly6C+ cells, than those of effector 
(TregEff) subset, perhaps limiting the peripheral abundancy of the 
former subsets. The possibility of differential degree of TCR self-
recognition was indeed supported by moderately lower expression 
of CD5 and Nur77, levels of which are known to correlate with 
the strength of TCR affinity for self-pMHC ligands (7), in TregN 
Ly6C+ subset than those of both TregN Ly6C− and TregEff subsets 
(Figure S1A in Supplementary Material). This was also in line with 
a modest reduction in the basal phosphorylation of CD3ζ chain, 
indicative of the extent of TCR self-reactivity, in TregN Ly6C+ 
subset compared to Ly6C− subsets as reported previously (4).
We next examined whether such subtle difference in TCR 
signaling derived from self-recognition contributes to generating 
naive Treg, especially TregN Ly6C+ cells, and determining their 
overall size in the periphery under steady state. To address this 
in an unbiased system, we first used monoclonal OT-II TCR 
transgenic system specific for MHC-II-restricted ovalbumin 
(Ova) antigen and generated mixed BM chimera. For BM donors, 
OT-II.Rag1−/− BM cells were combined with a titrated number of 
mixed BM cells from CD11c DOG.Rag1−/− mice—which encode 
Ova transgene under control of CD11c promoter (14) and express 
FigUre 2 | Impact of variable quantities of T cell receptor self-recognition on TregN Ly6c+ subset generation. (a) Bone marrow (BM) cells from CD11c.DOG 
Rag1−/− were mixed with BM cells from wild-type WT Rag1−/− mice at the indicated ratio and then this mixture of BM cells (50%) were mixed again with BM cells 
from OT-II Thy1.1+ Foxp3-eGFP Rag1−/− mice (50%). These BM cell mixtures were injected into irradiated (300 cGy) Rag1−/− hosts. At 8 weeks after BM cell  
transfer, cells from peripheral lymph node (PLN) were analyzed by flow cytometry for Ly6C expression and CD5. Shown are gated on Thy1.1+ CD4+ Foxp3+  
cells. (B) Cell tracker violet (CTV) labeled, indicated number of CD8-depleted thymocytes from Thy1.1+ Foxp3-eGFP mice were injected into irradiated B6  
hosts and then proliferation and Ly6C expression were analyzed on day 14 after transfer. Shown are proliferation and the Ly6C expression on donor Thy1.1+  
Foxp3+ CD4+ cells in PLN. The data are representative of three experiments comprising four to five mice per group. *p < 0.05, **p < 0.01, and ***p < 0.001.
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Ova in dendritic cells (DCs) as a cognate self-antigen—and 
from WT B6 mice, and then intravenously (i.v.) injected into 
irradiated Rag1−/− hosts (Figure 2A, top). In these BM chimeras, 
thymic development of OT-II Treg would require high affinity 
interaction of OT-II TCR with Ova peptide bound to MHC-II 
in the thymus, presumably with variable efficacy depending 
on the relative amounts of Ova self-antigen presented by DC 
derived from CD11c DOG BM. At 8  weeks after BM transfer, 
we indeed found the variable frequency of peripheral OT-II Treg 
generation, with the frequency being higher at 1:2 ratio than at 
1:4 (and also 1:8) ratio of CD11c DOG BM to WT BM (Figure 
S2A in Supplementary Material). In contrast to the frequency 
of total peripheral OT-II Treg, however, the reverse applied to 
the frequency of Ly6C-expressing naive OT-II Treg generation 
(Figure  2A, bottom left); thus, the frequency of TregN Ly6C+ 
OT-II cells was far greater at 1:4 ratio than at 1:1 and 1:2 ratio 
of CD11c DOG BM to WT BM. Notably, the higher frequency 
of Ly6C+ Treg generation was associated with their low expres-
sion of CD5, whereas the lower generation was associated with 
the high expression of CD5 (Figure  2A, bottom right). These 
results suggest strong inverse correlation between the efficacy of 
Ly6C expression on Treg and the amounts of self-pMHC ligands 
present in vivo.
To further confirm such inverse relationship between the 
amounts of TCR self-recognition and generation of TregN Ly6C+ 
subset, we next used an adoptive transfer of polyclonal repertoire 
of thymic Treg precursor cells into lymphopenic hosts. For this, 
either a small or large number of CD4+ CD8− thymocytes (that 
are Ly6C–; 25 × 106 or 2.5 × 106, respectively) were injected i.v. 
into irradiated B6 hosts (Figure 2B, top), in which the donor cells 
undergo lymphopenia-induced homeostatic proliferation (LIP) 
in a manner dependent on TCR self-interaction. At 14 days after 
transfer, several rounds of Treg cell proliferation were observed in 
both groups; however, the extent of proliferation was much greater 
with transfer of 2.5 × 106 donor cells than transfer of 25 × 106 
donor cells, as assessed by CTV dye dilution (Figure 2B, bottom 
left) and expression of activation markers CD43 and CD62L 
(Figure S2B in Supplementary Material). In sharp contrast to the 
proliferative responses, the extent of TregN Ly6C+ cell generation 
was far less with transfer of 2.5 × 106 donor cells than transfer of 
25 × 106 donor cells (Figure 2B, bottom right). These data suggest 
that adoptive transfer of smaller numbers of thymocytes results 
in less TCR competition for self-ligands, thereby inducing more 
intense TCR self-recognition and much lower efficacy of Ly6C+ 
Treg generation. Together, these results strongly support the 
idea that the generation of peripheral naive TregN Ly6C+ subset 
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actively involves the relatively lower quantity of TCR signaling 
derived from contacts with self-pMHC ligands.
Poor responsiveness of ly6c+ naive  
Treg subset to Tonic Tcr stimuli
Given the requirement of relatively lower intensity of TCR 
self-recognition for inducing TregN Ly6C+ cells, we next exam-
ined whether and how this feature relates to their functional 
responsiveness. In this regard, previous studies have shown that 
the Ly6C+ Treg cells exhibit lower levels of intracellular Ki-67 
expression, a marker indicative of cell proliferation, compared 
to those of Ly6C− Treg cells (4). We therefore sought to address 
whether such poor proliferative capacity of Ly6C+ Treg is a 
simple reflection of their activation status as a resting naive pool 
or a direct consequence of their lower degree of TCR signaling. 
To address this, we first analyzed in  vivo proliferation of Treg 
subsets by feeding Foxp3-GFP reporter mice with BrdU for 
10 days in drinking water (Figure 3A, top). In agreement with the 
previous report (4), effector Treg subset (Ly6C− CD43+) exhibited 
a substantial degree of proliferation, whereas naive Treg subsets, 
especially Ly6C+ CD43− cells, almost failed to do so, although 
Ly6C− CD43− cells showed only a little proliferation (Figure 3A, 
bottom). The data therefore support again the prior notion of 
the close relationship between Treg activation status and their 
functional responsiveness.
Based on the abovementioned result, we next examined 
whether the lack of in  vivo proliferation of Ly6C+ Treg subset 
results from their lower quantity of TCR self-recognition under 
steady state condition. To this end, we adoptively transferred 
FACS-purified peripheral Treg donor subsets (i.e., TregEff CD43+, 
TregN Ly6C–, and TregN Ly6C+; Figure S3A in Supplementary 
Material) into lymphodeplete irradiated B6 hosts (Figure  3B, 
top), in which the relative intensity of TCR signaling driven 
by self-recognition rises substantially to drive LIP of Treg 
cells (Figure 2B). At day 7 after adoptive transfer, as expected, 
Ly6C− subsets of both effector and to a lesser extent naive cells 
exhibited significant levels of proliferative responses (Figure 3B, 
bottom); interestingly, however, this response was largely abro-
gated in TregN Ly6C+, even though a significant proportion of 
this TregN Ly6C+ subset exhibited signs of cellular activation such 
as upregulation of CD43 and downregulation of Ly6C. We also 
confirmed these findings by adoptive transfer of the above FACS-
purified Treg subsets into unmanipulated lymphoreplete B6 hosts 
(Figures S3B,C in Supplementary Material) These data suggest 
that the TregN Ly6C+ subset, unlike its Ly6C− naive counterparts, 
is somewhat refractory to tonic TCR stimuli both in a normal 
lymphoreplete and even in a lymphodeplete condition, with poor 
in vivo proliferative responses.
We then examined whether the refractory nature of tonic 
TCR signaling of TregN Ly6C+ subset is due to the ignorance of 
their TCR to an array of peripheral cognate self-pMHC ligands. 
This issue is of particular interest as this TregN Ly6C+ subset has 
been shown to display a skewed TCR repertoire compared to 
both Ly6C− TregN and TregEff subsets (18). To address this, we 
used Treg subsets purified from H2M−/− mice that present only a 
single CLIP peptide bound to MHC-II molecules (CLIP-pMHC) 
in both thymus and periphery, generating limited TCR repertoire 
diversity (10). FACS-purified H2M−/− Treg subsets (Thy1.1+) 
were adoptively transferred into H2M−/− recipient hosts on a 
Rag1-deficient background (H2M−/− Rag1−/−) (Figure 3C, top), 
in which donor Treg cells would undergo LIP dependent on 
tonic TCR signaling via its uniform recognition of a single self-
antigen, CLIP-pMHC ligands. At day 7 after adoptive transfer, 
Ly6C− subsets of both naive and effector H2M−/− Treg cells 
exhibited a substantial degree of LIP, whereas TregN Ly6C+ cells 
failed to undergo LIP (Figure 3C, bottom), which was consistent 
with the results obtained from irradiated B6 hosts (Figure 3B). 
Together, all these results strongly suggest that TregN Ly6C+ cells 
are indeed a poor responder to tonic TCR stimuli, regardless of 
quantitative and even qualitative difference in any given self-
pMHC ligands, and perhaps have a unique TCR tuning mecha-
nism to maintain their functional quiescence under steady state 
condition.
age-Dependent conversion from  
Tregn ly6c+ to Tregeff subset
Given the poor responsiveness of TregN Ly6C+ subset to tonic 
TCR stimuli, this subset may not be able to persist in the periph-
ery for a longer period of time under steady state. In order to 
overcome this, it is possible that TregN Ly6C+ cells may depend 
on additional cues other than self-ligands for their survival and 
maintenance. In fact, relatively a shorter life-span of the TregN 
Ly6C+ subset was reported previously, showing a uniform reduc-
tion of this subset in aged mice, with enhanced levels of their 
apoptosis compared to those of Ly6C− Treg subset (4). Likewise, 
in a time course analysis for naive (Ly6C+) versus effector 
(CD43+) Treg subset, we found the increase in the frequency of 
the TregN Ly6C+ subset during perinatal to a young adult period, 
with reaching a peak at ~8–10 weeks of age, but then uniform 
gradual decrease afterward over 50  weeks of age (Figure  4A). 
Similar data were also obtained in the absolute number of these 
Treg subsets with age (data not shown). Survival differences 
between Ly6C+ and Ly6C− Treg subsets may account for this 
phenomenon. The age-dependent decline of Ly6C+ subset, 
however, was not a result of their increased apoptotic death, as 
assessed by the reduced amounts of Annexin V staining for naive 
TregN Ly6C+ (and also TregN Ly6C−) subset compared to those 
of TregEff subset (Figure 4B); here, the lower levels of apopto-
sis of TregN subsets appeared to be similar for both young 
(8-week-old) and old (1-year-old) mice. Moreover, consistent 
with the diminished apoptosis, TregN subsets—regardless of 
age—exhibited higher expression of anti-apoptotic protein Bcl-2 
than TregEff cells (Figure 4C), which was also in close agreement 
with a recent report showing a higher level of Bcl-2 for Ly6C+ 
naive than for Ly6C− effector Treg (18). Based on these data 
showing lower ex vivo apoptosis and higher Bcl-2 expression, 
we further confirmed the survival difference of Treg subsets 
in vitro by measuring spontaneous cell death in culture (Figure 
S4A in Supplementary Material); again, the results clearly showed 
much less apoptotic death in TregN subsets than in TregEff.
The gradual reduction of TregN Ly6C+ subset in the aged mice 
despite their enhanced ability for survival suggests an existence 
FigUre 3 | Poor responsiveness of TregN Ly6C+ subset to tonic T cell receptor stimuli. (a) Foxp3-eGFP mice were fed with 0.8 mg/ml of bromodeoxyuridine (BrdU) 
in drinking water for 10 days and then BrdU uptake levels on different subsets of T regulatory (Treg) were analyzed on day 10. Cell tracker violet-labeled Treg subsets 
from Thy1.1+ Foxp3-eGFP mice (B) or Thy1.1+ Foxp3-eGFP H2M−/− mice (c) were injected into irradiated B6 (B) or H2M−/− Rag1−/− (c) hosts and then proliferations 
of donor Treg cells were analyzed on day 7 after transfer. The data are representative of three to four experiments comprising four to five mice per group. *p < 0.05, 
**p < 0.01, and ***p < 0.001.
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FigUre 4 | Age-dependent disappearance of TregN Ly6C+ is not correlated with increased apoptosis in aged mice. (a) Peripheral lymph node cells from Foxp3-
eGFP mice of various ages indicated were stained with CD43, CD4, Ly6C, and PI. Shown are CD43 and Ly6C expression on CD4+ eGFP+ cells (left) and statistics 
(right). (B) T regulatory (Treg) subsets from young (8 weeks) or aged (1 year) mice Foxp3-eGFP mice were stained with Annexin V, CD4, PI, Ly6C, and CD62L. 
Shown are gated on PI− CD4+ eGFP+ Treg (top left) and then gated on indicated markers. (c) Treg subsets from young (8 weeks) or aged (1 year) mice Foxp3-eGFP 
mice were analyzed for Bcl-2 expression. The data are representative of three experiments comprising two to three mice per group. *p < 0.05, **p < 0.01, and 
***p < 0.001.
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of additional mechanism by which this subset is actively removed 
in an age-dependent manner. Phenotypic conversion from Ly6C+ 
into Ly6C− Treg subset via downregulation of Ly6C expression on 
the former was the most plausible explanation with the following 
two observations. First, levels of Ly6C were decreased substan-
tially when TregN Ly6C+ cells were stimulated by TCR ligation 
with anti-CD3 and anti-CD28 antibodies in vitro (Figure S4B in 
Supplementary Material), which was consistent with previously 
reported findings in  vitro (4) and our prior adoptive transfer 
data with this subset in lymphopenic hosts in vivo (Figure 3B). 
Second, the age-dependent change of the peripheral frequency 
of TregEff CD43+ subset was in sharp contrast to those of TregN 
Ly6C+ subset, with the proportion of the former being decreased 
during perinatal to the young adult period but then being 
gradually increased thereafter with age (Figure 4A). Besides the 
age-dependent frequency change, it should be noted that TregEff 
cells from young vs. aged mice showed similar levels of expres-
sion of various Treg surface markers (i.e., CD43, CD62L, CD103, 
GITR, and ICOS), except for CD69, CTLA4, and PD-1 (Figure 
S4C in Supplementary Material and data not shown). These data 
together support the idea of an age-dependent transition from 
TregN Ly6C+ to TregEff subset.
We then examined the underlying mechanisms of Treg 
phenotypic conversion in aged mice. To this end, we first sought 
to define essential factor(s) that promotes such age-dependent 
conversion and tested a possibility of whether this phenomenon 
is attributed to enhanced activation of TregN Ly6C+ subset pre-
sumably via occasional increase of foreign environmental anti-
gens in aged mice housed under SPF condition. This possibility, 
however, was not the case, as the enhanced frequency of TregEff 
subset (along with reduced frequency of Ly6C+ Treg subset) was 
similarly observed both in aged SPF mice and in aged GF and 
even dietary AF mice (data not shown). This finding seems to 
rule out a role of innocuous foreign antigens, such as commensal 
microbiota and foods, yet highlights a possible involvement of 
self-antigens perhaps in conjunction with other age-dependent 
FigUre 5 | Age-dependent conversion of TregN Ly6C+ subset into TregEff. T regulatory (Treg) subsets from Thy1.1 + Foxp3-eGFP were labeled with cell tracker 
violet and then injected into differentially aged hosts. Donor cell proliferation was analyzed 3 weeks after transfer. The data are representative of three experiments 
comprising three to five mice per group. *p < 0.05, **p < 0.01, and ***p < 0.001.
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homeostatic cues. We thus further assessed whether there are any 
age-dependent cues that can facilitate the phenotypic conversion 
of TregN Ly6C+ subset. To address this, we adoptively transferred 
either FACS-purified Ly6C+ or Ly6C− naive (CD62Lhi CD43−) 
Treg subset into recipient mice of different ages (ranging from 
2 to 14 months of age; Figure 5, top). At 3 weeks after transfer 
into 2-month-old young recipient mice, as expected, a large 
majority of TregN Ly6C+ cells compared to Ly6C− Treg cells were 
barely dividing with only about ~8% of cells proliferating and 
downregulating Ly6C (Figure 5, bottom). Notably, however, the 
proportion of these responses significantly increased up to ~40% 
with adoptive transfer into 8-month-old recipient mice, and 
even further increased up to ~65% after transfer into 14-month-
old recipient mice, a level of which was near identical to those 
seen after transfer with Ly6C− Treg subset into these aged hosts 
(Figure 5, bottom right).
Together, these data strongly suggest that while the respon-
siveness of TregN Ly6C+ subset to tonic TCR stimuli is actively 
suppressed under steady-state environment of young adult mice, 
this subset in older mice may have a unique ability to sense a 
certain age-dependent cue and switch from naive to effector 
phenotype.
role of conventional effector T cells  
in the age-Dependent Treg conversion
In an attempt to define the nature of an age-dependent homeo-
static cue that promotes most likely TregN Ly6C+ conversion 
into TregEff, we determined if such conversion is correlated 
with the large increase in conventional effector/memory CD4 
T cell populations (TconvEff) which are known to be generated 
spontaneously under steady state and gradually increased in 
number with age (19). In comparison of these cells from mice 
at different ages, their frequencies in the spleen were indeed 
largely increased in older mice (12-month-old and to a lesser 
extent 4 months old; ~42 and 30%, respectively) compared to 
those of young mice (2-month-old; ~18%), with a conventional 
CD44hi CD62Llo profile characteristic of effector/memory 
phenotype (Figure S5A in Supplementary Material), perhaps 
correlating to the enhanced conversion of TregN Ly6C+ to 
TregEff in the older mice (Figure 5). Likewise, the similar rela-
tionship between the increase of TconvEff cells and augmented 
Treg conversion from naive to TregEff was also observed in aged 
thymectomized mice, in which CD4 TconvEff pools (CD43+ 
Ly6C−) are known to increase (Figure S5B in Supplementary 
Material). Thus, peripheral TconvEff cells in 9-month-old 
thymectomized mice were observed with ~4-fold increase in 
their frequency relative to those seen in sham-thymectomized 
mice, correlating with enhanced Treg conversion from TregN 
Ly6C+ to TregEff CD43+ subset in the former (Figure S5B in 
Supplementary Material).
To gain more direct evidence supporting the roles of TconvEff 
populations in contributing to the TregN Ly6C+ conversion, 
we used two different approaches that can generate increased 
amounts of TconvEff cells at variable degrees depending on differ-
ent immune environment of experimental mice being engaged. 
First, we adoptively transferred either TregN subset (either Ly6C+ 
or Ly6C−) alone or a mixture of Treg and naive CD4 T cells into 
GF Rag1−/− hosts (Figure 6A, top); here, the latter cotransferred 
naive CD4 T  cells undergo moderate but significant activation 
and proliferation to differentiate into functional TconvEff cells 
(data not shown) (20). At day 7 after adoptive transfer, TregN 
Ly6C− subset underwent similar degree of robust prolifera-
tion, regardless of whether recipient mice were coinjected with 
naive CD4 T  cells (Figure  6A, bottom). Importantly, however, 
TregN Ly6C+ subset, although failed to proliferate alone, showed 
FigUre 6 | Role of TconvEff cells in functional restoration of TregN Ly6C+ cells. (a) T regulatory (Treg) subsets from Thy1.1+ Foxp3-eGFP mice were labeled with cell 
tracker violet (CTV) and then injected into germ-free Rag1−/− hosts in the presence or absence of naive CD4 T cells. Shown are proliferations of donor Treg subsets 
on day 7. (B) Treg subsets from Thy1.1+ Foxp3-eGFP mice were labeled with CTV and then injected into wild type or Foxp3-DTR hosts. The hosts were treated with 
1 µg of diphtheria toxin in every other day. Donor cell proliferation was analyzed on day 7 after transfer. The data are representative of three to four experiments 
comprising three to four mice per group. *p < 0.05, **p < 0.01, and ***p < 0.001.
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significantly increased levels of proliferation only with the aid of 
cotransferred naive CD4 T cells (Figure 6A, bottom). Second, we 
adoptively transferred TregN Ly6C+ or TregN Ly6C− subsets into 
either WT or Foxp3-DTR (DT receptor) mice (Figure 6B, top), in 
which depletion of the host Foxp3+ Treg by DT injection results in 
robust activation/expansion of host naive CD4 T cells and gener-
ate TconvEff populations (13). At day 7 after adoptive transfer and 
DT treatment, donor TregN Ly6C+ subset showed no prolifera-
tion, although TregN Ly6C− subset proliferated moderately in WT 
hosts (Figure 6B, bottom). In marked contrast, however, TregN 
Ly6C+ subset showed vigorous proliferation comparable to those 
of TregN Ly6C− subset in Foxp3-DTR hosts (Figure 6B, bottom). 
Together, these findings strongly suggest that TconvEff cells play a 
critical role in converting TregN Ly6C+ subset to become TregEff 
subset.
role of il-2 in the effector conversion of 
ly6c+ Treg subset and their Proliferation
We next investigated how TconvEff populations promote effector 
conversion and subsequent proliferation of TregN Ly6C+ subset. 
For this, we sought to test a possibility that the effects by TconvEff 
cells are perhaps mediated indirectly by providing additional 
homeostatic cues such as IL-2 in particular, as IL-2 is well 
documented to be essential for many aspects of peripheral Treg 
homeostasis, including their survival and function (12, 21), and 
also known to be produced mainly from activated CD4 TconvEff 
populations (21). In fact, all purified Treg subsets (TregN Ly6C+, 
TregN Ly6C−, and TregEff) proliferated equally well in vitro when 
responding to exogenous IL-2 and TCR ligation with anti-CD3 
(Figure S6A in Supplementary Material), suggesting a potential 
FigUre 7 | Role of IL-2 in TconvEff-driven functional recovery of TregN Ly6C+ subset. (a) Cell tracker violet (CTV)-labeled T regulatory (Treg) subsets were injected 
into wild-type (WT) hosts on day 0 and then IL-2/anti-IL-2 complexes were daily injected on days 0–2. Proliferations of donor Treg subsets were analyzed on day 7. 
(B) CTV-labeled Treg subsets were injected into WT or IL-2−/− hosts on day 0 and then donor Treg proliferations were analyzed on day 7. The data are representative 
of three experiments comprising three mice per group. *p < 0.05, **p < 0.01, and ***p < 0.001.
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effect of IL-2 on TregN Ly6C+ subset. To further address the 
role of IL-2 in converting TregN subsets in vivo, we used a well-
established approach of enhancing in vivo biological activity of 
IL-2. For this, a complex form of IL-2 and anti-IL-2 (JES6-1 for 
Treg-specific activity (22)) was injected into B6 mice that were 
adoptively transferred with either purified naive (TregN Ly6C+ 
and TregN Ly6C−) or effector (TregEff) Treg subsets (Figure 7A, 
top). In analysis of IL-2-uninjected recipient mice on day 7, both 
TregN Ly6C− and TregEff donor subsets showed a moderate level 
of proliferation (~25% by CTV dilution), whereas TregN Ly6C+ 
subset did not (Figure 7A, bottom left). By contrast, proliferation 
of all these Treg subsets was significantly increased by adminis-
tration of IL-2, although the degree of proliferation was far lower 
for TregN Ly6C+ than for both TregN Ly6C− and TregEff subsets 
(Figure 7A, bottom right).
Despite moderate enhancement in proliferation by IL-2 injec-
tion, the proliferative capacity of TregN Ly6C+ subset was still 
incomplete with little or no downregulation of Ly6C expression 
(Figure S6B in Supplementary Material), and the levels were 
far lower than those of both TregN Ly6C− and TregEff subsets 
(Figure 7A). This suggest that the effect of injected IL-2 might 
be insufficient for TregN Ly6C+ subset by a competition with 
existing host TregN population whose proliferation was also 
enhanced by IL-2 (Figure S6C in Supplementary Material). 
Alternatively, it is also possible that full recovery of proliferation 
for TregN Ly6C+ subset depends on either additional different 
cytokines other than IL-2 or mixtures of such various cytokines 
including IL-2. To directly address a role of endogenous IL-2 
in  vivo, we adoptively transferred purified TregN Ly6C+ subset 
into either WT or IL-2−/− mice (Figure  7B, top); noted that 
the latter mice lack Treg development and therefore exhibit 
uncontrolled activation/expansion of host T  cell populations 
(12). At day 7 after transfer, donor TregN Ly6C+ subset barely 
proliferated in WT hosts but surprisingly this subset showed a 
substantial degree of proliferation in IL-2−/− hosts (Figure  7B, 
bottom). This result therefore suggests that IL-2 alone is perhaps 
not an essential cytokine cue per  se but rather other single or 
combinations of various proinflammatory cytokines, which 
are likely to be present at relatively high concentrations in 
hyperlymphoproliferative environment of IL-2−/− hosts, might 
be involved. In support of this, addition of IL-4, IL-21, and 
TNF-α to the culture of TregN Ly6C+ subset in vitro significantly 
FigUre 8 | Restoration of immune-suppressive activity of TregN Ly6C+ cells. (a) T regulatory (Treg) subsets from Thy1.1+ Foxp3-eGFP mice were labeled with cell 
tracker violet and then injected into wild-type or Foxp3-DTR hosts. The hosts were treated with 1 µg of diphtheria toxin in every third day until day 14. Shown are 
FACS plots for CD44 and CD62L expressions on host CD4 and CD8 T cells in PLN on day 14 after transfer of Treg subsets. Absolute cell numbers (B) and 
frequencies (B,c) for the gated subsets indicated were calculated based on the data shown in (a). The data are representative of three experiments comprising 
three to five mice per group. *p < 0.05, **p < 0.01, and ***p < 0.001.
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enhanced their anti-CD3-induced proliferation (Figure S6D in 
Supplementary Material). Importantly, the enhancing effect of 
these additional cytokines on the anti-CD3-induced in vitro pro-
liferation of Ly6C+ Treg cells was largely recapitulated by simple 
coculture with naive CD4 T cells (Figure S6E in Supplementary 
Material), further supporting a role of TconvEff cells. Collectively, 
these findings strongly suggest that TconvEff cells contribute to 
enhancing proliferation and conversion of TregN Ly6C+ subset 
into TregEff, presumably by providing single or several essential 
cytokine cue(s).
recovery from Poor immunosuppressive 
Function of Tregn ly6c+ subset
Given the previously reported poor immunosuppressive activity 
of Ly6C+ Treg cells in vitro and in vivo (4), we sought to address 
a possibility that these cells may regain their suppressive ability 
with the aid of TconvEff cells. To this end, we utilized again the 
aforementioned Foxp3-DTR mice system to generate an abun-
dant supply of TconvEff pools and adoptively transferred purified 
Treg subsets (TregN Ly6C+, TregN Ly6C−, and TregEff) into these 
mice followed by DT treatment (Figure  8, top). Although the 
expansion of TregN Ly6C+ subset was lower than that of TregN 
Ly6C− subset on day 7 (Figure 6B), at day 14 after transfer and 
DT treatment, we confirmed a similar degree of expansion of all 
donor Treg subsets in both frequency and numbers (Figure S7A 
in Supplementary Material). Based on such efficient expansion of 
donor Treg subsets, we then compared their relative suppressive 
capacity for preventing host naive T cells from being activated, 
expanded, and differentiated into conventional effector popula-
tions that are CD44hi CD62Llo.
As shown in Figure  8A, frequencies of CD44hi CD62Llo 
CD4 and CD8 effector T cells generated in Foxp3-DTR mice 
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after DT treatment were significantly reduced by adoptively 
transferred TregN Ly6C− and TregEff subsets, compared to those 
generated in control DT-treated Foxp3-DTR mice with no 
Treg cell transfer, which was in agreement with their known 
suppressive activity reported previously (13). Likewise, TregN 
Ly6C+ donor subset  also showed a significant degree of sup-
pressive effects on the generation of CD44hi CD62Llo effector 
T cell populations from DT-treated Foxp3-DTR mice, although 
level of such suppression was slightly less effective than that 
of Ly6C− Treg subsets (Figures  8A,B). In sharp contrast to 
the reduced frequency of CD44hi CD62Llo effector T cells, the 
relative proportion of CD44lo CD62Lhi naive CD4 and CD8 
T cells in Foxp3-DTR mice after DT treatment was increased 
by adoptively transferred Treg subsets (Figures 8A,B). In close 
accord with the strong suppressive activity observed, TregN 
Ly6C+ donor subset in Foxp3-DTR mice after DT treatment 
displayed upregulation of various Treg functional markers, 
such as CTLA-4, LAP, GARP, and GITR, at levels similar to 
those seen in TregN Ly6C− and TregEff subsets (Figure S7B in 
Supplementary Material). Besides the enhanced expression of 
these Treg suppressive markers, TregN Ly6C+ cells in Foxp3-
DTR mice after DT treatment also showed the ability to pro-
duce immune-suppressive cytokine IL-10, at levels comparable 
to those seen in TregEff cells (Figure S7C in Supplementary 
Material). Moreover, the TregN Ly6C+ subset in DT-treated 
Foxp3-DTR mice appeared to gain a full proliferative potential 
even in a TconvEff-free environment of irradiated hosts (Figure 
S8 in Supplementary Material); here, adoptive transfer of TregN 
Ly6C+ subset purified from day 14 DT-treated Foxp3-DTR 
mice showed massive proliferation, whereas freshly isolated 
TregN Ly6C+ counterparts failed to show such proliferation. 
Collectively, all these findings provide strong evidence that 
TregN Ly6C+ subset in a “hyperimmune” environment bearing 
large numbers of TconvEff populations can switch their resting 
naive state into effector state, thereby regaining immune-
suppressive activity to maintain self-tolerance.
DiscUssiOn
In this study, we demonstrated that generation and maintenance 
of Ly6C+ Treg cells in the peripheral lymphoid organs are regu-
lated by a unique mechanism distinctly different from those of 
Ly6C− Treg populations. Consistent with other previous studies, 
the Ly6C+ Treg cells displayed all features characteristics of 
naive cells in their surface phenotypes, activation status, and 
functional responses in steady state condition, resulting in a 
poor degree of proliferative capacity and an impaired immune-
suppressive activity. Although Ly6C+ Treg subset appeared to 
be non-functional and gradually lost with augmented apoptotic 
death with age in the previous studies (4), we demonstrated here 
that these cells could actively change their phenotype and func-
tion from naive to effector cells with a “help” from conventional 
effector T  cell populations. Our findings therefore imply an 
existence of a homeostatic cross-talk between peripheral Treg 
pools and conventional effector T  cells and highlight a physi-
ological importance of Ly6C+ Treg subset for the maintenance 
of self-tolerance.
The naive phenotypes of Ly6C+ Treg subset with a poor 
functional responsiveness was well defined to be correlated by 
relatively low degree of TCR self-reactivity (4), which was consist-
ent with the fact that these cells express a slightly reduced level 
of CD5 and Nur77 compared to those of Ly6C− Treg subsets. 
It is therefore conceivable that any postthymic Treg precursor 
cells newly entering into the periphery would have a potential 
to induce Ly6C and become Ly6C+ Treg subset, only if they have 
a relatively low intrinsic TCR affinity for self-ligands. In fact, a 
previous study reported, however, that large majority of Ly6C− 
Treg precursor cells rapidly gained Ly6C expression shortly after 
adoptive transfer into MHC-II−/− recipient hosts that are lacking 
self-pMHC ligands (4). This finding suggests that the ability of 
individual Treg precursor cells to become Ly6C+ Treg is perhaps 
much less dependent on their lower intrinsic TCR affinity for 
self per  se but rather largely influenced negatively by a relative 
abundancy of self-ligands being engaged with any given TCR 
repertoire. In light of this view, we demonstrated that OT-II CD4 
T cells could exhibit a variable capacity to become Ly6C+ Treg 
subset in mixed BM chimera, depending on the relative amounts 
of Ova presented as a cognate self-antigen. Likewise, we also 
showed that Ly6C+ Treg cell generation from thymic Treg precur-
sor cells transferred into irradiated B6 hosts varied depending 
on the overall size of the donor cells that are competing for 
self-ligands. These findings therefore indicate that the potential 
of inducing Ly6C+ Treg is determined in a flexible manner by 
relative abundancy of self-ligands rather than by intrinsic TCR 
affinity for them.
If any given TCR can respond to lower amounts of self-ligands 
and mediate Ly6C+ Treg generation from most Treg precursors, 
one may expect that the impaired proliferative responses of 
Ly6C+ Treg cells is perhaps due to their interactions with too 
much low levels of cognate self-ligands, resulting from either 
competition for or scarcity of those self-ligands. This possibility 
was not the case, however, by the fact that Ly6C+ Treg cells from 
H2M−/− mice, in which all Treg cells are positively selected by 
only a single self-peptide CLIP from the thymus and maintained 
by interactions with the same CLIP self-antigen in the periphery, 
still exhibited a profound defect in their ability to proliferate after 
adoptive transfer into H2M−/− (on a lymphopenic Rag1−/− back-
ground) hosts. These results therefore suggest that once any given 
Treg precursor cells are induced to differentiate into Ly6C+ Treg 
cells, the resulting population may lose their functional ability 
to respond to even the same quantity and quality of a cognate 
self-ligand being engaged in the presence and even in the absence 
of clonal competition. Although underlying mechanisms remain 
unclear, this phenomenon observed in Ly6C+ Treg cells appeared 
to resemble activated conventional T  cells in an anergic state 
(23), as was evident for their poor functional responsiveness 
with impaired in vivo proliferation. We demonstrated, however, 
that unlike those of anergic T cells with a permanent functional 
failure, the impaired function for Ly6C+ Treg cells was not 
retained in an irreversible manner but rather recovered actively 
by a certain cue derived from convention effector/memory T cell 
populations (see below).
Regaining functional responsiveness of Ly6C+ Treg cells was 
apparent in an environment of aged mice in particular. At first 
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glance, the results showing a much lower proportion of Ly6C+ 
Treg cells than Ly6C− CD43+ effector Treg cells in the aged mice 
seemed to reflect a gradual disappearance of the former subset 
due to their enhanced apoptotic death as reported previously (4). 
However, we could detect no such obvious enhancement in the 
apoptosis of Ly6C+ Treg cells and instead found much reduced 
levels of apoptosis (Annexin V+ cells) compared to Ly6C− CD43+ 
Treg cells ex vivo, perhaps correlating with their increased levels 
of Bcl-2 expression (18). In an attempt of searching other possible 
explanation, downregulation of Ly6C expression on Ly6C+ Treg 
cells has been demonstrated in an in vitro culture with anti-CD3-
induced TCR stimulation although the similar phenomenon has 
not been addressed in  vivo (4). Direct evidence as to whether 
such downregulation indeed occurs in vivo and accounts for the 
substantial reduction of Ly6C+ Treg population in aged mice 
came from the results showing markedly enhanced phenotypic 
conversion from Ly6C+ Treg to Ly6C− Treg after adoptive transfer 
into an older (14 months old) but not a young (2 months old) 
recipient host. Moreover, in agreement with the observed altera-
tions in Ly6C expression, the converted Treg cells appeared to 
be functional with increased proliferative potential and upregula-
tion of various Treg surface markers in these aged hosts. These 
findings therefore support the above notion that Ly6C+ Treg 
cells are not a permanently “anergic” in their functional status 
but rather persisted transiently in a “tuned” state perhaps by a 
unique mechanism that can dynamically modulate their activa-
tion threshold for responsiveness to tonic TCR stimuli from 
self-interactions. An exact mechanism by which the Ly6C+ Treg 
cells are tuned and how they can be relieved from such tuning in 
a milieu of aged mice will need to be investigated.
With regard to the factors that can promote the age-dependent 
alterations of Ly6C+ Treg cells, we could demonstrate a close 
relationship of such phenomenon with peripheral abundancy 
of CD44hi CD62Llo conventional effector T  cell populations, a 
number of which is directly proportional to the age of host mice. 
In addition to the results from the older mice, this correlation 
was also evident from two other findings even in a young adult 
host adoptively transferred with purified Ly6C+ Treg: here, 
enhanced responsiveness of this subset occurred either (1) when 
cotransferred with conventional CD4 T  cells into GF Rag1−/− 
hosts or (2) when transferred into Foxp3-DTR hosts with DT 
treatment. Each of these hosts could generate a large number of 
effector T cell populations and was found to result in substantial 
increase of proliferative responses of the donor Ly6C+ Treg with 
a concomitant downregulation of Ly6C expression, an upregula-
tion of effector Treg markers, and a functional restoration of 
immune-suppressive activity. Possible mechanism underlying 
the impact of such effector populations on Ly6C+ Treg is unclear 
yet nevertheless it seems apparent that this phenomenon could 
not be explained by IL-2 alone produced by effector T cells, as 
the phenotypic conversion and increased functional alteration of 
Ly6C+ Treg cells were still observed even in a IL-2-deficient host. 
Although the data from IL-2−/− mice ruled out the sole effect 
of IL-2 alone, role of other pro-inflammatory cytokines (either 
as a single or in combinations) that are abundant in this hyper-
immune milieu is still open in question, as we demonstrated the 
enhancing effects of IL-4, IL-21, and TNF-α on anti-CD3-induced 
Ly6C+ Treg proliferation in  vitro. These observations with 
cytokines, together with the similar (and even greater) enhanc-
ing effect of coculture of naive CD4 T cells on Treg proliferation 
in vitro, would seem to provide strong support, if not proof, for 
the possibility that Ly6C+ Treg cells are a unique in their property 
to respond to a certain rise of either single or mixture of cytokines 
produced from effector T cells. Precisely how the TconEff cells are 
activated in a manner dependent on specific immune environ-
ment of aging or inflammation, and produce sufficient amounts 
of stimulatory cytokines for naive Treg remains to be addressed. 
Also, a possibility that the age- or inflammation-dependent effect 
on naive Treg cells is a simple reflection of their different immune 
niche is needed to be clarified.
Besides the potential role of cytokine cues in converting 
functional status of Ly6C+ Treg cells, our study does not rule out 
a role of additional extrinsic factors other than cytokines. For 
instance, effector T cells might provide a different form of “help” 
on Ly6C+ Treg cells either by a direct T cell–T cell interaction via 
costimulatory molecules, such as CD40L–CD40, or through an 
indirect modulation of DC activity via upregulating ligand mol-
ecules for DC–Treg interactions, including self-pMHC as well as 
CD80, CD86, and ICOSL (24–26). In light of the latter view, it 
is possible that activation of conventional effector CD4 and/or 
CD8 T  cells may produce various proinflammatory cytokines, 
which can in turn either activate a steady-state DC or convert 
a “tolerogenic” DC into stimulatory DC, thereby allowing them 
to promote functional restoration of Ly6C+ Treg cells. Therefore, 
further investigation as to whether the enhanced DC activation 
indeed occurs preferentially in the aged mice (and also in IL-2-
deficient or DT-treated Foxp3-DTR mice) and whether such 
effects are independent of commensal microbial and/or dietary 
food antigens and thus still achievable even in the aged GF or AF 
mice will be of interest to be performed.
Collectively, all these findings suggest that despite the above-
mentioned various possible mechanisms, effector T  cells play a 
critical role in rescuing a tuned state of Ly6C+ Treg cells. Given that 
such “detuning” process is accompanied by subsequent alterations 
in their phenotype and function with regaining immune-suppres-
sive activity, we propose that peripheral Ly6C+ Treg cells under 
steady state may serve as a natural reservoir to supply functional 
effector Treg cells in a directional (from Ly6C+ CD62Lhi naive into 
Ly6C− CD62Lhi naive and then into Ly6C− CD62Llo CD43+ effec-
tor Treg) and also highly regulated manner—which is of particular 
importance in the aged mice in which thymic Treg generation is 
severely decreased due to thymic involution. This study therefore 
provides better understanding for a unique property of Ly6C+ 
Treg population and their role in maintaining self-tolerance.
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